Adocia SA Sustainability Reports

Adocia S.A. is a clinical-stage biotechnology company that designs and develops therapeutic solutions for chronic metabolic diseases. The company specializes in creating innovative formulations of insulins and other metabolic hormones to improve treatments for diabetes and obesity.

Sector: Professional & technical services

Country: France

Exchange: Euronext Paris

LEI: 969500ZL79KYH9PTYP78

FIGI: BBG001T7D103

5 reports from 2022 to 2025

• Adocia SA 2025 Universal Registration Document
• Adocia SA 2025 Universal Registration Document
• Adocia SA 2024 Universal Registration Document
• Adocia SA 2023 Universal Registration Document
• Adocia SA 2022 Universal Registration Document